Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 18 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 10881653

    Tricyclic compounds and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  2. US 10881722

    Epizootic hemorrhagic disease vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  3. US 10882886

    Adeno-associated virus polynucleotides, polypeptides and virions

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (WASHINGTON DC) · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  4. US 10875860

    Azaindenoisoquinoline compounds and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  5. US 10876003

    Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  6. US 10876123

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  7. US 10870687

    Anti-human papillomavirus 16 E7 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  8. US 10869865

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  9. US 10869856

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  10. US 10869920

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  11. US 10865389

    DNA vaccines against foot-and-mouth disease virus

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  12. US 10864285

    Methods for the diagnosis and treatment of Sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  13. US 10858634

    Vaccines and pharmaceutical compositions against foot-and-mouth disease virus

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  14. US 10858633

    Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modified FMDV 3C protease

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  15. US 10849975

    Multivalent vaccines for rabies virus and filoviruses

    The United States of America, as Represented by the Secretary, Department of Health and Human Services Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  16. US 10849960

    Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  17. US 10849912

    Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  18. US 10844387

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  19. US 10836721

    Thalidomide analogs and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  20. US 10837019

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  21. US 10837003

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  22. US 10836759

    Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  23. US 10835593

    Modified anthrax toxin protective antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  24. US 10829768

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.